A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis
1999 ◽
Vol 159
(6)
◽
pp. 1814-1818
◽
2003 ◽
Vol 111
(2)
◽
pp. S147
2006 ◽
Vol 35
(02)
◽
pp. 117
◽
2013 ◽
Vol 62
(1)
◽
pp. 37-43
◽
2000 ◽
Vol 84
(2)
◽
pp. 176-187
◽
2015 ◽
Vol 212
(1)
◽
pp. S176